Fixed combination of calcipotriol and betamethasone dipropionate in the treatment of psoriasis: case-based analysis

Close metadata

Recommended articles:

The role of telemedicine in dermatology with examples on the organization of services for patients with psoriasis and acne. Russian Journal of Clinical Dermatology and Venereology. 2024;(2):111-117

The use of systemic cytoprotective therapy in association with combination topical therapy on the basis of salicylic acid and glucocorticosteroids in psoriasis vulgaris. Russian Journal of Clinical Dermatology and Venereology. 2024;(2):168-172

Psoriasis exudativa in patient with hereditary hemorrhagic telangiectasia. Russian Journal of Clinical Dermatology and Venereology. 2024;(4):356-361

Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Venereology. 2024;(5):517-524

New aspects of psoriasis pathogenesis: metabolomic profiling in dermatology. Russian Journal of Clinical Dermatology and Venereology. 2024;(5):526-531

Study of the effectiveness of different methods of external psoriasis therapy in a new experimental model of chronic inflammation. Russian Journal of Clinical Dermatology and Venereology. 2024;(5):552-557

Psoriasis: analysis of comorbid pathology. Russian Journal of Clinical Dermatology and Venereology. 2025;(1):16-21

Morbidity of Psoriasis and psoriatic arthritis in the Republic of Bashkortostan in 2012—2022. Russian Journal of Preventive Medicine. 2024;(7):38-45

Modern approaches to rational combination pharmacotherapy of allergic rhinitis. Russian Bulletin of Otorhinolaryngology. 2024;(4):68-77

Differentiated approach to the choice of agents for pathogenetic drug therapy in patients with allergic rhinitis. Russian Rhinology. 2025;(1):18-26

Treatment of psoriasis is a very challenging task, implying the choice of the drug, which is not only highly effective and well-tolerated, but also provides a high patient’s compliance with the treatment. The results of randomized clinical trials (RCTs) showed that a fixed combination of calcipotriol and betamethasone dipropionate, which should be administered ones per day, provides significant improvement in symptoms compared not only with placebo, but also with each of the components prescribed as monotherapy. The data of previous Russian retrospective study confirmed the results obtained in RCTs and demonstrated both increased clinical efficacy and cost effectiveness when using the fixed combination of calcipotriol/betamethasone dipropionate compared to the fixed combination of mometasone furoate/salicylic acid. Currently, the cost of treatment with the fixed combination of calcipotriol/betamethasone dipropionate is comparable to that of therapy with original mometasone furoate/salicylic acid, and even with generic drug available present at the Russian pharmaceutical market. Therefore, the fixed combination of calcipotriol/betamethasone dipropionate is a feasible choice in the treatment of mild to moderate psoriasis both from clinical and economical viewpoint.

Keywords:

psoriasis

vitamin D analogues

steroids

fixed combination

Authors:

Rudakova A.V.

GBOU VPO «Sankt-Peterburgskaja himiko-farmatsevticheskaja akademija», Sankt-Peterburg, Rossija, 197376

Lvov A.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

List of references:

Lebwohl M. Psoriasis. Lancet 2003; 361:1197-204.
National Psoriasis Foundation. Topical treatments. National Psoriasis Foundation website.www.psoriasis.org/about-psoriasis/treatments/topicals. Accessed January 7, 2015.
Menter A, Korman NJ, Elmets CA et al; American Academy of Dermatology. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J. Am. Acad. Dermatol. 2009; 60: 643-659.
Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J. Am. Acad. Dermatol. 2008; 58: 826-850.
Yamauchi P. Vitamin D analogues and corticosteroids in the treatment of plaque psoriasis. January 18, 2015 http:. drugtopics.modernmedicine.com
Katz HI, Hien NT, Prawer SE, et al. Superpotent topical steroid treatment of psoriasis vulgaris-clinical efficacy and adrenal function. J. Am. Acad. Dermatol. 1987; 16: 804-811.
Devaux S, Castela A, Archier E, et al. Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review. J. Eur. Acad. Dermatol. Venereol. 2012; 26 (Suppl 3): 52-60.
Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension prescribing information. Parsippany, NJ: LEO Pharma; 2014.
van de Kerkhof PC, Steegers-Theunissen RP, Kuipers MV. Evaluation of topical drug treatment in psoriasis. Dermatology 1998; 197: 31-36.
Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch. Dermatol. 2004; 140: 408-414.
Bottomley J, Taylor R, Ryttov J. The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderately severe scalp psoriasis: A systematic review of direct and indirect evidence. Current Medical Research & Opinion 2011; 27 (1): 251-268.
Van de Kerkhof P, de Peuter R, Ryttov J, et al. Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris. Curr. Med. Res. Opin. 2011; 27: 225-38.
Hendriks AG, Keijsers RR, de Jong EM, Seyger MM, van de Kerkhof PC. Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: a systematic literature review. J. Eur. Acad. Dermatol. Venereol. 2013; 27: 931-951.
Mason A, Mason J, Cork M, Hancock H, Dooley G. Topical treatments for chronic plaque psoriasis: an abridged Cochrane systematic review. J. Am. Acad. Dermatol. 2013; 69: 799-807.
Kragballe K, van de Kerkhof P. Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp. J. Eur. Acad. Dermatol. Venereol. 2014; 28 (Suppl 2): 10-21.
Taraska V, Tuppal R, Olesen M, et al. A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris. Journal of Cutaneous Medicine and Surgery, Aug 2015; 10.1177/1203475415597094.
McCormack PL. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp. Drugs 2011; 71: 709-730.
Ivanov OL, L'vov AN, Khaldin AA. Retrospective comparative analysis of the costs and effectiveness of two different regimens of combination topical treatment of psoriasis vulgaris (calcipotriol/betamethasone dipropionate compared to mometasone furoate/salicylic acid). Rossiiskii zhurnal kozhnykh i venericheskikh boleznei 2007; 4: 25–29. (in Russ).
Kochergin NG. Osnovnye aspekty patogeneza, kliniki i sovremennoi terapii atopicheskogo dermatita. Doctor of Medicine Thesis. Moscow, 2001. (in Russ).
Lambert et al. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study. J. Eur. Acad. Dermatol. Venereol. 2014; doi: 10.1111/jdv.12387

Close metadata